BEAM FY 2020 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$24,000+33.3% YoY

Gross Profit

-$103M-429812.5% margin

Operating Income

-$133M-553166.7% margin

Net Income

-$195M-810800.0% margin

EPS (Diluted)

$-5.49

Cash Flow

Operating Cash Flow

-$96M

Free Cash Flow

-$112M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$452M

Total Liabilities

$206M

Stockholders' Equity

$246M

Cash & Equivalents

$162M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24,000	$18,000	+33.3%
Gross Profit	-$103M	-$55M	-88.9%
Operating Income	-$133M	-$75M	-76.7%
Net Income	-$195M	-$78M	-148.4%